Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Jurjen Versluis, Yael Flamand, MS, Erika J. Haydu, MD PhD, Rahul S. Vedula, MD, Anne Charles, BS, Kevin Copson, MA, Ofir Wolach, MD, Pavan Bendapudi, MD, Roger Belizaire, MD PhD, Donna S. Neuberg, ScD, Marlise R Luskin, MDMS, R. Coleman Lindsley, MD PhD

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-137741

Published: 2020

Journal Articles

Oncogenic Mechanisms of CBL E3 Ubiquitin Ligase Mutations in Myeloid Malignancies

Roger Belizaire, MD PhD, Sebastian Koochaki, BS, MS, Namrata Udeshi, PhD, Alexis Vedder, BS, Lei Sun, Monica Schenone, PhD, Steven Carr, PhD, Eric Padron, MD, Benjamin L. Ebert, MD PhD

Blood (2019) 134 (Supplement_1): 563.

https://doi.org/10.1182/blood-2019-122503

Published: 2019

Journal Articles

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56 bright NK Cells in Patients with Chronic Gvhd

Tomohiro Kubo, MD PhD, Rizwan Romee, MD, John Koreth, MBBS, DPhil, Roger Belizaire, MD PhD, Yusuke Kamihara, MD PhD, Hongye Liu, PhD, Takeru Asano, MDPhD, Jennifer Whangbo, MD PhD, Masahiro Hirakawa, MD PhD, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Vincent T. Ho, MD, Corey S. Cutler, MD MPH, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, Jerome Ritz, MD PhD

Blood (2018) 132 (Supplement 1): 606.

https://doi.org/10.1182/blood-2018-99-109918

Published: 2018

Journal Articles

Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates

John Koreth, MBBS, DPhil, Haesook T Kim, PhD, Roger Belizaire, MD PhD, Samuel J Poryanda, BSc, Carol Reynolds, PhD, Jennifer Whangbo, MD PhD, Sarah Nikiforow, Edwin Alyea, III, MD, Philippe Armand, MD PhD, Corey Cutler, MD MPH, FRCPC, Vincent T Ho, MD, Bruce Blazar, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Robert J. Soiffer, MD

Blood (2017) 130 (Supplement 1): 515.

https://doi.org/10.1182/blood.V130.Suppl_1.515.515

Published: 2017

Journal Articles

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

Zuzana Tothova, MD PhD, John M Krill-Burger, MCS, Katerina D Popova, BA, Quinlan Sievers, BA, David Yudovich, BSc, Roger Belizaire, MD PhD, Jon C. Aster, MD PhD, Elizabeth A. Morgan, MD, Aviad Tsherniak, MSc, Benjamin L Ebert, MD PhD

Blood (2016) 128 (22): 741.

https://doi.org/10.1182/blood.V128.22.741.741

Published: 2016

Journal Articles

Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach

Roger Belizaire, MD, PhD, Olga Pozdnyakova, MD, PhD, Daniel J. DeAngelo, MD, PhD, Betty Li, MS, MT(ASCP), Karry Charest, MT(ASCP), Richard M. Stone, MD, Martha Wadleigh, MD, David P. Steensma, MD, Gabriela Motyckova, MD, PhD, David M. Dorfman, MD, PhD

Blood (2013) 122 (21): 1378.

https://doi.org/10.1182/blood.V122.21.1378.1378

Published: 2013

NARROW

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Oncogenic Mechanisms of CBL E3 Ubiquitin Ligase Mutations in Myeloid Malignancies

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56 bright NK Cells in Patients with Chronic Gvhd

Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach

Email alerts

ASH Publications

American Society of Hematology

Incidence and Risk Factors for Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Oncogenic Mechanisms of CBL E3 Ubiquitin Ligase Mutations in Myeloid Malignancies

Low-Dose Interleukin-2 Therapy Enhances Cytotoxicity of CD56 bright NK Cells in Patients with Chronic Gvhd

Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates

Generation of Models of Human Hematologic Malignancies Using CRISPR Genome Engineering

Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only